Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The research interests of Sylvie Girard, Ph.D., focus on the immune contribution to pregnancy complications, as well as the negative impact on the placenta and maternal and infant health. Dr. Girard is particularly interested in the diagnostic potential of inflammatory markers for early detection of women at high risk of pregnancy complications, such as preterm birth and preeclampsia. She is also working on the identification and development of novel therapeutic strategies targeting the immune system to protect the placenta and neonate against long-term developmental disorders.
There are very limited therapeutic possibilities available for pregnancy complications, despite the substantial short- and long-term health impacts for both mother and child. The overarching goal of Dr. Girard's research is to understand the detrimental effects that inflammation and immune dysregulation during pregnancy have on placental function that lead to adverse health outcomes. This will allow for novel target identification and therapeutic strategy development, ultimately protecting both the mother and infant during pregnancy and postpartum.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.